This company has been acquired
THRN Stock Overview
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Thorne HealthTech, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.19 |
| 52 Week High | US$10.20 |
| 52 Week Low | US$3.41 |
| Beta | 0.82 |
| 1 Month Change | 0.39% |
| 3 Month Change | 93.36% |
| 1 Year Change | 128.48% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 34.97% |
Recent News & Updates
Recent updates
Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 12
Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar
Jun 07Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist
Dec 17Thorne HealthTech Grows But Faces Macro Headwinds
Sep 09Thorne HealthTech's blood collection device OneDraw gets clearance in Japan
Aug 23Thorne HealthTech swings to Q2 Non-GAAP loss per share, revenue down Y/Y, FY22 guidance revised
Aug 09Thorne HealthTech: Poised To Outperform Other Nutraceutical Companies
Jun 05Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality
Mar 23Thorne HealthTech: Good Potential At A Low Price
Jan 11Shareholder Returns
| THRN | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0.1% | -1.1% | 0.4% |
| 1Y | 128.5% | -25.9% | 23.1% |
Return vs Industry: THRN exceeded the US Personal Products industry which returned -31.9% over the past year.
Return vs Market: THRN exceeded the US Market which returned 14.1% over the past year.
Price Volatility
| THRN volatility | |
|---|---|
| THRN Average Weekly Movement | 12.1% |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.7% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: THRN's share price has been volatile over the past 3 months.
Volatility Over Time: THRN's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 544 | Paul Jacobson | www.thorne.com |
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual’s health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health.
Thorne HealthTech, Inc. Fundamentals Summary
| THRN fundamental statistics | |
|---|---|
| Market cap | US$550.63m |
| Earnings (TTM) | US$20.33m |
| Revenue (TTM) | US$258.01m |
27.1x
P/E Ratio2.1x
P/S RatioIs THRN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THRN income statement (TTM) | |
|---|---|
| Revenue | US$258.01m |
| Cost of Revenue | US$127.58m |
| Gross Profit | US$130.43m |
| Other Expenses | US$110.10m |
| Earnings | US$20.33m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.38 |
| Gross Margin | 50.55% |
| Net Profit Margin | 7.88% |
| Debt/Equity Ratio | 16.1% |
How did THRN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/18 14:33 |
| End of Day Share Price | 2023/10/13 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Thorne HealthTech, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Bryan Spillane | BofA Global Research |
| Susan Anderson | Canaccord Genuity |